Medexus Pharma:Stocks Analysts Recently Upgraded on TSX (MDP)
Medexus Pharmaceuticals Inc is among the group of Toronto Stock Exchange stocks recently upgraded by analysts. This means each stock on this list has seen its averge consensus value move up in the last week, so at least one analyst has upgraded their view on these stocks.
This report is generated monthly. It displays the number of analysts along with their buy-hold-sell ratings for the company. A company is included when its mean rating increases from the previous week. Stocks in this category are held primarily for capital appreciation.
Companies can get upgraded for a number of reasons - but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.
| Symbol | Name | Buy | Out Perform | Hold | Under Perform | Sell | No Opinion | Mean Rating | Prev Mean Rating | Mean Label |
|---|---|---|---|---|---|---|---|---|---|---|
| CTC-A | Canadian Tire Corp Ltd | 2 | 1 | 6 | 1 | 0 | 0 | 3.4 | 3.2 | Hold |
| CTC | Canadian Tire Corp Ltd | 2 | 1 | 6 | 1 | 0 | 0 | 3.4 | 3.2 | Hold |
| TOY | Spin Master Corp | 6 | 1 | 1 | 0 | 0 | 0 | 4.625 | 4.375 | Buy |
| CRR-UN | Crombie Real Estate Investment Trust | 5 | 2 | 1 | 0 | 0 | 0 | 4.5 | 4.25 | Outperform |
| KNT | K92 Mining Inc | 6 | 2 | 1 | 0 | 0 | 0 | 4.5556 | 4.3333 | Buy |
| KSI | kneat.com Inc | 2 | 3 | 0 | 0 | 0 | 0 | 4.4 | 4.2 | Outperform |
| MDP | Medexus Pharmaceuticals Inc | 2 | 3 | 1 | 0 | 0 | 0 | 4.1667 | 4 | Outperform |
All data provided as of August 08, 2024.
More about Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.
Medexus Pharmaceuticals Inc is listed under MDP on the Toronto Stock Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
